Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Yesterday
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.

UDCA for primary sclerosing cholangitis may lower biliary tract cancer risk

Roshini Claire Anthony
22 Dec 2020

Patients with primary sclerosing cholangitis (PSC) who are treated with ursodeoxycholic acid (UDCA) may have a lower risk of liver transplantation, all-cause death, or biliary tract cancer, according to a study from Japan.

Using the Japanese PSC registry which comprises 435 patients with PSC, investigators of this observational study identified and enrolled the 325 patients who met study criteria* (median age 45.8 years, 57.5 percent male). Eighty-six and 24 percent of patients were treated with UDCA and bezafibrate, respectively, with 202 and two patients, respectively, receiving these drugs as monotherapy, and 76 as combination therapy. Forty-five patients did not receive treatment.

The median observation period was 5.1 years, during which time there were 57 deaths. Twenty-four patients underwent liver transplantation. Biliary tract cancer occurred in 26 patients, which were primarily of the bile duct (n=22), while the remaining four patients developed gallbladder cancer.

Treatment with UDCA was associated with a reduced risk of all-cause death or need for liver transplantation compared with non-receipt of UDCA (adjusted hazard ratio [adjHR], 0.467, 95 percent confidence interval [CI], 0.280–0.778; p=0.003). [AASLD 2020, abstract 100]

Women treated with UDCA had a reduced risk of all-cause death or liver transplantation (adjHR, 0.57; p=0.018), while older age (adjHR, 2.04; p<0.001), presence of symptoms (adjHR, 2.13; p=0.003), albumin <3.5 g/dL (adjHR, 3.80; p<0.001), and AST >30 U/L (adjHR, 2.52; p=0.033) were associated with an increased risk.

A model adjusted for inverse probability treatment weighting (IPTW) showed that the improvement in liver transplantation-free survival with UDCA treatment remained significant (adjHR, 0.429, 95 percent CI, 0.245–0.753; p=0.02). The primary analysis results also remained significant in the sensitivity analysis comparing patients who received UDCA monotherapy vs untreated patients (n=247; adjHR, 0.55; p=0.032).

UDCA treatment was also tied to a reduced risk of biliary tract cancer (adjHR, 0.324, 95 percent CI, 0.135–0.778; p=0.012). The significance was lost in the IPTW model (adjHR, 0.42; p=0.10), though the findings remained significant in the sensitivity analysis (adjHR, 0.39; p=0.043).

Increasing age was associated with an increased risk of biliary tract cancer (adjHR, 2.70; p<0.001), while the risk was reduced in women (adjHR, 0.34; p=0.029).

Due to the lack of alternative medical treatment options for PSC, UDCA is frequently used as a first-line treatment for most patients with PSC in Japan, noted study author Dr Toshihiko Arizumi from the Teikyo University School of Medicine, Tokyo, Japan, who presented the findings on behalf of the Japan PSC Study Group at the AASLD 2020 Liver Meeting.

This is despite it remaining unclear if UDCA confers long-term benefits in the treatment of PSC, he said.

“In this Japanese PSC cohort, UDCA treatment was significantly associated with an improvement in liver transplantation-free survival,” said Arizumi.

UDCA was also likely to be associated with a reduction in biliary tract cancer, though this result was not consistently significant, he continued, pointing out that the small sample size was at least partly to blame.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Yesterday
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.